» Articles » PMID: 33349053

Intravenously Injected Pluripotent Stem Cell-derived Cells Form Fetomaternal Vasculature and Prevent Miscarriage in Mouse

Overview
Journal Cell Transplant
Date 2020 Dec 22
PMID 33349053
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Miscarriage is the most common complication of pregnancy, and about 1% of pregnant women suffer a recurrence. Using a widely used mouse miscarriage model, we previously showed that intravenous injection of bone marrow (BM)-derived endothelial progenitor cells (EPCs) may prevent miscarriage. However, preparing enough BM-derived EPCs to treat a patient might be problematic. Here, we demonstrated the generation of mouse pluripotent stem cells (PSCs), propagation of sufficient PSC-derived cells with endothelial potential (PSC-EPs), and intravenous injection of the PSC-EPs into the mouse miscarriage model. We found that the injection prevented miscarriage. Three-dimensional reconstruction images of the decidua after tissue cleaning revealed robust fetomaternal neovascularization induced by the PSC-EP injection. Additionally, the injected PSC-EPs directly formed spiral arteries. These findings suggest that intravenous injection of PSC-EPs could become a promising remedy for recurrent miscarriage.

Citing Articles

ALKBH5 modulation of ferroptosis in recurrent miscarriage: implications in cytotrophoblast dysfunction.

Qin C, Wu J, Wei X, Liu X, Lin Y PeerJ. 2024; 12:e18227.

PMID: 39434797 PMC: 11493020. DOI: 10.7717/peerj.18227.


Clinical Application of Spiral CT Reconstruction Imaging in Patients with Tracheal Stenosis before Anesthesia.

Dai S, Yao Y, Xia D Contrast Media Mol Imaging. 2022; 2022:9633527.

PMID: 36105451 PMC: 9444445. DOI: 10.1155/2022/9633527.

References
1.
Roberts J, Hubel C . The two stage model of preeclampsia: variations on the theme. Placenta. 2008; 30 Suppl A:S32-7. PMC: 2680383. DOI: 10.1016/j.placenta.2008.11.009. View

2.
Hayashi K, Ohta H, Kurimoto K, Aramaki S, Saitou M . Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell. 2011; 146(4):519-32. DOI: 10.1016/j.cell.2011.06.052. View

3.
Girardi G, Yarilin D, Thurman J, Holers V, Salmon J . Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006; 203(9):2165-75. PMC: 2118387. DOI: 10.1084/jem.20061022. View

4.
Jivraj S, Anstie B, Cheong Y, Fairlie F, Laird S, Li T . Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study. Hum Reprod. 2001; 16(1):102-106. DOI: 10.1093/humrep/16.1.102. View

5.
Sano T, Terai Y, Daimon A, Nunode M, Nagayasu Y, Okamoto A . Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsia. Placenta. 2018; 65:1-6. DOI: 10.1016/j.placenta.2018.03.006. View